echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Clinical Nutrition: The bioavailability of 25(OH)D is related to the clinical outcome of patients with diffuse large B-cell lymphoma

    Clinical Nutrition: The bioavailability of 25(OH)D is related to the clinical outcome of patients with diffuse large B-cell lymphoma

    • Last Update: 2021-03-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Diffuse large B-cell lymphoma (DLBCL) is one of the most invasive subtypes of non-Hodgkin’s lymphoma (NHL), accounting for 30-40% of NHL patients.


    Diffuse large B-cell lymphoma (DLBCL) is one of the most invasive subtypes of non-Hodgkin’s lymphoma (NHL), accounting for 30-40% of NHL patients.


     

     

     

    A total of 332 newly diagnosed DLBCL patients were recruited for this study .


    diagnosis

     

     

     

    Among these patients, 92.


     

     

    This study confirmed that the bioavailability level of 25(OH)D can be used as a new prognostic biomarker for DLBCL patients.


    This study confirmed that the bioavailability level of 25(OH)D can be used as a new prognostic biomarker for DLBCL patients.


     

    Original source:

    Peizhan Chen.


    Bioavailable 25(OH)D level is associated with clinical outcomes of patients with diffuse large B-cell lymphoma: An exploratory study.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.